Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin

被引:50
作者
Di Paolo, E
De Neef, P
Moguilevsky, N
Petry, H
Bollen, A
Waelbroeck, M
Robberecht, P
机构
[1] Univ Libre Bruxelles, Dept Biochem & Nutr, Fac Med, B-1070 Brussels, Belgium
[2] Free Univ Brussels, Fac Sci, B-1050 Brussels, Belgium
关键词
secretin receptor; mutagenesis; secretin analogue;
D O I
10.1016/S0014-5793(98)00175-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The secretin amino-terminal residues are essential for high affinity binding to its cognate receptor and for its biological activity, Mutation of the [Asp(3)] residue of secretin to [Asn(3)] decreased the ligand's affinity for the rat wild-type receptor 100-300-fold, Receptor mutations in the transmembrane 2 domain and the beginning of the first extracellular loop allowed the identification of three residues involved in recognition of the [Asp(3)] residue: D174, K173 and R166, Mutation of K173 and D174 not only reduced the secretin and [Asn(3)]secretin affinities, but also changed the receptor's selectivity as judged by a decreased secretin and [Asn(3)]secretin potency ratio, The most striking effect was observed when R166 was mutated to Q, D or L, This led to receptors with a very low affinity for secretin but an up to 10-fold higher affinity than the wild-type receptor for [Asn(3)]secretin. This suggested that R166, highly conserved in that subgroup of receptor, is a major determinant for the recognition of the [Asp(3)] of the ligand, (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 27 条
[1]   EXPRESSION CLONING OF A HUMAN CORTICOTROPIN-RELEASING-FACTOR RECEPTOR [J].
CHEN, RP ;
LEWIS, KA ;
PERRIN, MH ;
VALE, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8967-8971
[2]   PROPERTIES OF THE VIP-PACAP TYPE-II RECEPTOR STABLY EXPRESSED IN CHO CELLS [J].
CICCARELLI, E ;
VILARDAGA, JP ;
DENEEF, P ;
DIPAOLO, E ;
WAELBROECK, M ;
BOLLEN, A ;
ROBBERECHT, P .
REGULATORY PEPTIDES, 1994, 54 (2-3) :397-407
[3]   PHARMACOLOGICAL PROPERTIES OF 2 RECOMBINANT SPLICE VARIANTS OF THE PACAP TYPE-I RECEPTOR, TRANSFECTED AND STABLY EXPRESSED IN CHO CELLS [J].
CICCARELLI, E ;
SVOBODA, M ;
DENEEF, P ;
DIPAOLO, E ;
BOLLEN, A ;
DUBEAUX, C ;
VILARDAGA, JP ;
WAELBROECK, M ;
ROBBERECHT, P .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 288 (03) :259-267
[4]   Vasoactive intestinal peptide (VIP)(1) receptor - Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamide [J].
Couvineau, A ;
RouyerFessard, C ;
Maoret, JJ ;
Gaudin, P ;
Nicole, P ;
Laburthe, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12795-12800
[5]   The arrangement of the transmembrane helices in the secretin receptor family of G-protein-coupled receptors [J].
Donnelly, D .
FEBS LETTERS, 1997, 409 (03) :431-436
[6]   Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production [J].
Du, K ;
Nicole, P ;
Couvineau, A ;
Laburthe, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 230 (02) :289-292
[7]   Transmembrane residues of the parathyroid hormone (PTH)/PTH-related peptide receptor that specifically affect binding and signaling by agonist ligands [J].
Gardella, TJ ;
Luck, MD ;
Fan, MH ;
Lee, CW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12820-12825
[8]   GLUCAGON-LIKE PEPTIDE-I ANALOGS - EFFECTS ON INSULIN-SECRETION AND ADENOSINE-3',5'-MONOPHOSPHATE FORMATION [J].
GEFEL, D ;
HENDRICK, GK ;
MOJSOV, S ;
HABENER, J ;
WEIR, GC .
ENDOCRINOLOGY, 1990, 126 (04) :2164-2168
[9]   Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor [J].
Gourlet, P ;
Vilardaga, JP ;
DeNeef, P ;
Vandermeers, A ;
Waelbroeck, M ;
Bollen, A ;
Robberecht, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 239 (02) :349-355
[10]   The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors [J].
Gourlet, P ;
Vilardaga, JP ;
DeNeef, P ;
Waelbroeck, M ;
Vandermeers, A ;
Robberecht, P .
PEPTIDES, 1996, 17 (05) :825-829